APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tuberculosis Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tuberculosis Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchTuberculosis Treatment Drugs Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Tuberculosis Treatment Drugs Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Tuberculosis Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tuberculosis Treatment Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Tuberculosis Treatment Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Tuberculosis Treatment Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Tuberculosis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tuberculosis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tuberculosis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tuberculosis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tuberculosis Treatment Drugs include Labatec Pharma, Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Pfizer, Eli Lilly, Mylan, Novartis and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tuberculosis Treatment Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tuberculosis Treatment Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tuberculosis Treatment Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tuberculosis Treatment Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Tuberculosis Treatment Drugs Segment by Company

Labatec Pharma

Lupin

Macleods Pharmaceuticals

Otsuka Pharmaceutical

Pfizer

Eli Lilly

Mylan

Novartis

Johnson & Johnson

Sanofi

Tuberculosis Treatment Drugs Segment by Type

Active TB

Latent TB

Tuberculosis Treatment Drugs Segment by Application

Hospital

Clinic

Drugstore

Tuberculosis Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tuberculosis Treatment Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tuberculosis Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Tuberculosis Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Tuberculosis Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Tuberculosis Treatment Drugs Industry Trends Table 2. Tuberculosis Treatment Drugs Industry Drivers Table 3. Tuberculosis Treatment Drugs Industry Opportunities and Challenges Table 4. Tuberculosis Treatment Drugs Industry Restraints Table 5. Global Tuberculosis Treatment Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Tuberculosis Treatment Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Tuberculosis Treatment Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Tuberculosis Treatment Drugs Sales Market Share by Manufacturers Table 9. Global Tuberculosis Treatment Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Tuberculosis Treatment Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Tuberculosis Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Tuberculosis Treatment Drugs Manufacturers, Product Type & Application Table 13. Global Tuberculosis Treatment Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Tuberculosis Treatment Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Active TB Table 17. Major Manufacturers of Latent TB Table 18. Global Tuberculosis Treatment Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Tuberculosis Treatment Drugs Sales by Type (2021-2026) & (k units) Table 20. Global Tuberculosis Treatment Drugs Sales by Type (2027-2032) & (k units) Table 21. Global Tuberculosis Treatment Drugs Sales Market Share by Type (2021-2026) Table 22. Global Tuberculosis Treatment Drugs Sales Market Share by Type (2027-2032) Table 23. Global Tuberculosis Treatment Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Tuberculosis Treatment Drugs Revenue by Type (2021-2026) & (k units) Table 25. Global Tuberculosis Treatment Drugs Revenue by Type (2027-2032) & (k units) Table 26. Global Tuberculosis Treatment Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Tuberculosis Treatment Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Drugstore Table 31. Global Tuberculosis Treatment Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Tuberculosis Treatment Drugs Sales by Application (2021-2026) & (k units) Table 33. Global Tuberculosis Treatment Drugs Sales by Application (2027-2032) & (k units) Table 34. Global Tuberculosis Treatment Drugs Sales Market Share by Application (2021-2026) Table 35. Global Tuberculosis Treatment Drugs Sales Market Share by Application (2027-2032) Table 36. Global Tuberculosis Treatment Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Tuberculosis Treatment Drugs Revenue by Application (2021-2026) & (k units) Table 38. Global Tuberculosis Treatment Drugs Revenue by Application (2027-2032) & (k units) Table 39. Global Tuberculosis Treatment Drugs Revenue Market Share by Application (2021-2026) Table 40. Global Tuberculosis Treatment Drugs Revenue Market Share by Application (2027-2032) Table 41. Global Tuberculosis Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Tuberculosis Treatment Drugs Sales by Region (2021-2026) & (k units) Table 43. Global Tuberculosis Treatment Drugs Sales Market Share by Region (2021-2026) Table 44. Global Tuberculosis Treatment Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Tuberculosis Treatment Drugs Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Tuberculosis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Tuberculosis Treatment Drugs Sales by Country (2021-2026) & (k units) Table 48. North America Tuberculosis Treatment Drugs Sales by Country (2027-2032) & (k units) Table 49. Europe Tuberculosis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Tuberculosis Treatment Drugs Sales by Country (2021-2026) & (k units) Table 51. Europe Tuberculosis Treatment Drugs Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Tuberculosis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Tuberculosis Treatment Drugs Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Tuberculosis Treatment Drugs Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Tuberculosis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Tuberculosis Treatment Drugs Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Tuberculosis Treatment Drugs Sales by Country (2027-2032) & (k units) Table 58. Global Tuberculosis Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Tuberculosis Treatment Drugs Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Tuberculosis Treatment Drugs Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Tuberculosis Treatment Drugs Revenue Market Share by Region (2021-2026) Table 62. Global Tuberculosis Treatment Drugs Revenue Market Share by Region (2027-2032) Table 63. Labatec Pharma Company Information Table 64. Labatec Pharma Business Overview Table 65. Labatec Pharma Tuberculosis Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Labatec Pharma Tuberculosis Treatment Drugs Product Portfolio Table 67. Labatec Pharma Recent Development Table 68. Lupin Company Information Table 69. Lupin Business Overview Table 70. Lupin Tuberculosis Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Lupin Tuberculosis Treatment Drugs Product Portfolio Table 72. Lupin Recent Development Table 73. Macleods Pharmaceuticals Company Information Table 74. Macleods Pharmaceuticals Business Overview Table 75. Macleods Pharmaceuticals Tuberculosis Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Macleods Pharmaceuticals Tuberculosis Treatment Drugs Product Portfolio Table 77. Macleods Pharmaceuticals Recent Development Table 78. Otsuka Pharmaceutical Company Information Table 79. Otsuka Pharmaceutical Business Overview Table 80. Otsuka Pharmaceutical Tuberculosis Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Otsuka Pharmaceutical Tuberculosis Treatment Drugs Product Portfolio Table 82. Otsuka Pharmaceutical Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Tuberculosis Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Pfizer Tuberculosis Treatment Drugs Product Portfolio Table 87. Pfizer Recent Development Table 88. Eli Lilly Company Information Table 89. Eli Lilly Business Overview Table 90. Eli Lilly Tuberculosis Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Eli Lilly Tuberculosis Treatment Drugs Product Portfolio Table 92. Eli Lilly Recent Development Table 93. Mylan Company Information Table 94. Mylan Business Overview Table 95. Mylan Tuberculosis Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Mylan Tuberculosis Treatment Drugs Product Portfolio Table 97. Mylan Recent Development Table 98. Novartis Company Information Table 99. Novartis Business Overview Table 100. Novartis Tuberculosis Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Novartis Tuberculosis Treatment Drugs Product Portfolio Table 102. Novartis Recent Development Table 103. Johnson & Johnson Company Information Table 104. Johnson & Johnson Business Overview Table 105. Johnson & Johnson Tuberculosis Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Johnson & Johnson Tuberculosis Treatment Drugs Product Portfolio Table 107. Johnson & Johnson Recent Development Table 108. Sanofi Company Information Table 109. Sanofi Business Overview Table 110. Sanofi Tuberculosis Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Sanofi Tuberculosis Treatment Drugs Product Portfolio Table 112. Sanofi Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Tuberculosis Treatment Drugs Distributors List Table 116. Tuberculosis Treatment Drugs Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Tuberculosis Treatment Drugs Product Image Figure 2. Global Tuberculosis Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tuberculosis Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Tuberculosis Treatment Drugs Sales (2021-2032) & (k units) Figure 5. Global Tuberculosis Treatment Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Tuberculosis Treatment Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Active TB Image Figure 9. Latent TB Image Figure 10. Global Tuberculosis Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Tuberculosis Treatment Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Tuberculosis Treatment Drugs Sales Market Share by Type (2021-2032) Figure 13. Global Tuberculosis Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Tuberculosis Treatment Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Tuberculosis Treatment Drugs Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Drugstore Image Figure 19. Global Tuberculosis Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Tuberculosis Treatment Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Tuberculosis Treatment Drugs Sales Market Share by Application (2021-2032) Figure 22. Global Tuberculosis Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Tuberculosis Treatment Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Tuberculosis Treatment Drugs Revenue Market Share by Application (2021-2032) Figure 25. North America Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Tuberculosis Treatment Drugs Sales Market Share by Country (2021-2032) Figure 27. U.S. Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Tuberculosis Treatment Drugs Sales Market Share by Country (2021-2032) Figure 32. Germany Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Tuberculosis Treatment Drugs Sales Market Share by Country (2021-2032) Figure 39. China Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Tuberculosis Treatment Drugs Sales Market Share by Country (2021-2032) Figure 47. Brazil Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Tuberculosis Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Tuberculosis Treatment Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Tuberculosis Treatment Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Tuberculosis Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 58. North America Tuberculosis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Tuberculosis Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 60. Europe Tuberculosis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Tuberculosis Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Tuberculosis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Tuberculosis Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Tuberculosis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Tuberculosis Treatment Drugs Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Tuberculosis Treatment Drugs Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Active TB
  • Latent TB
Applications
  • Hospital
  • Clinic
  • Drugstore
Companies covered
  • Labatec Pharma
  • Lupin
  • Macleods Pharmaceuticals
  • Otsuka Pharmaceutical
  • Pfizer
  • Eli Lilly
  • Mylan
  • Novartis
  • Johnson & Johnson
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tuberculosis Treatment Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tuberculosis Treatment Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Tuberculosis Treatment Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Tuberculosis Treatment Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Tuberculosis Treatment Drugs Market Dynamics
  1. 2.1 Tuberculosis Treatment Drugs Industry Trends
  2. 2.2 Tuberculosis Treatment Drugs Industry Drivers
  3. 2.3 Tuberculosis Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Tuberculosis Treatment Drugs Industry Restraints
3 Tuberculosis Treatment Drugs Market by Manufacturers
  1. 3.1 Global Tuberculosis Treatment Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Tuberculosis Treatment Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Tuberculosis Treatment Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Tuberculosis Treatment Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tuberculosis Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Tuberculosis Treatment Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Tuberculosis Treatment Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tuberculosis Treatment Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tuberculosis Treatment Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tuberculosis Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Tuberculosis Treatment Drugs Market by Type
  1. 4.1 Tuberculosis Treatment Drugs Type Introduction
  2. 4.1.1 Active TB
  3. 4.1.2 Latent TB
  4. 4.2 Global Tuberculosis Treatment Drugs Sales by Type
  5. 4.2.1 Global Tuberculosis Treatment Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tuberculosis Treatment Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global Tuberculosis Treatment Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Tuberculosis Treatment Drugs Revenue by Type
  9. 4.3.1 Global Tuberculosis Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Tuberculosis Treatment Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global Tuberculosis Treatment Drugs Revenue Market Share by Type (2021-2032)
5 Tuberculosis Treatment Drugs Market by Application
  1. 5.1 Tuberculosis Treatment Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Drugstore
  5. 5.2 Global Tuberculosis Treatment Drugs Sales by Application
  6. 5.2.1 Global Tuberculosis Treatment Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tuberculosis Treatment Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Tuberculosis Treatment Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Tuberculosis Treatment Drugs Revenue by Application
  10. 5.3.1 Global Tuberculosis Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Tuberculosis Treatment Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Tuberculosis Treatment Drugs Revenue Market Share by Application (2021-2032)
6 Global Tuberculosis Treatment Drugs Sales by Region
  1. 6.1 Global Tuberculosis Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tuberculosis Treatment Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Tuberculosis Treatment Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Tuberculosis Treatment Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tuberculosis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Tuberculosis Treatment Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Tuberculosis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Tuberculosis Treatment Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Tuberculosis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Tuberculosis Treatment Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Tuberculosis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Tuberculosis Treatment Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Tuberculosis Treatment Drugs Revenue by Region
  1. 7.1 Global Tuberculosis Treatment Drugs Revenue by Region
  2. 7.1.1 Global Tuberculosis Treatment Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Tuberculosis Treatment Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Tuberculosis Treatment Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Tuberculosis Treatment Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Tuberculosis Treatment Drugs Revenue (2021-2032)
  8. 7.2.2 North America Tuberculosis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Tuberculosis Treatment Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Tuberculosis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Tuberculosis Treatment Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Tuberculosis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Tuberculosis Treatment Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Tuberculosis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Labatec Pharma
  2. 8.1.1 Labatec Pharma Company Information
  3. 8.1.2 Labatec Pharma Business Overview
  4. 8.1.3 Labatec Pharma Tuberculosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Labatec Pharma Tuberculosis Treatment Drugs Product Portfolio
  6. 8.1.5 Labatec Pharma Recent Developments
  7. 8.2 Lupin
  8. 8.2.1 Lupin Company Information
  9. 8.2.2 Lupin Business Overview
  10. 8.2.3 Lupin Tuberculosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lupin Tuberculosis Treatment Drugs Product Portfolio
  12. 8.2.5 Lupin Recent Developments
  13. 8.3 Macleods Pharmaceuticals
  14. 8.3.1 Macleods Pharmaceuticals Company Information
  15. 8.3.2 Macleods Pharmaceuticals Business Overview
  16. 8.3.3 Macleods Pharmaceuticals Tuberculosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Macleods Pharmaceuticals Tuberculosis Treatment Drugs Product Portfolio
  18. 8.3.5 Macleods Pharmaceuticals Recent Developments
  19. 8.4 Otsuka Pharmaceutical
  20. 8.4.1 Otsuka Pharmaceutical Company Information
  21. 8.4.2 Otsuka Pharmaceutical Business Overview
  22. 8.4.3 Otsuka Pharmaceutical Tuberculosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Otsuka Pharmaceutical Tuberculosis Treatment Drugs Product Portfolio
  24. 8.4.5 Otsuka Pharmaceutical Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Tuberculosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Tuberculosis Treatment Drugs Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly Tuberculosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly Tuberculosis Treatment Drugs Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan Tuberculosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Tuberculosis Treatment Drugs Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Novartis
  44. 8.8.1 Novartis Company Information
  45. 8.8.2 Novartis Business Overview
  46. 8.8.3 Novartis Tuberculosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novartis Tuberculosis Treatment Drugs Product Portfolio
  48. 8.8.5 Novartis Recent Developments
  49. 8.9 Johnson & Johnson
  50. 8.9.1 Johnson & Johnson Company Information
  51. 8.9.2 Johnson & Johnson Business Overview
  52. 8.9.3 Johnson & Johnson Tuberculosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Johnson & Johnson Tuberculosis Treatment Drugs Product Portfolio
  54. 8.9.5 Johnson & Johnson Recent Developments
  55. 8.10 Sanofi
  56. 8.10.1 Sanofi Company Information
  57. 8.10.2 Sanofi Business Overview
  58. 8.10.3 Sanofi Tuberculosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Tuberculosis Treatment Drugs Product Portfolio
  60. 8.10.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tuberculosis Treatment Drugs Value Chain Analysis
  2. 9.1.1 Tuberculosis Treatment Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tuberculosis Treatment Drugs Production Mode & Process
  6. 9.2 Tuberculosis Treatment Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tuberculosis Treatment Drugs Distributors
  9. 9.2.3 Tuberculosis Treatment Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst